Myogen
AcquiredWestminster, United States · Founded 2001
- Headquarters
- Westminster, Colorado
- Employees
- 51–200
- Founded
- 2001
- Business Model
- B2B
- Website
- myogen.com
- Last Round
- Series DAug 2003
- Rounds
- 4
About
Myogen was a privately held biopharmaceutical company headquartered in Westminster, Colorado, dedicated to discovering, developing, and commercializing drugs for heart failure and related cardiovascular conditions, including pulmonary arterial hypertension. Founded as a spin-off from the University of Colorado, Myogen advanced two key compounds before being acquired by Gilead Sciences in 2006 for $2.5 billion.
Summary
Myogen is a Biotech company based in Westminster, United States, founded in 2001. Its most recent funding was a Series D round in Aug 2003. Investors include BA Venture Partners, Gilead Sciences and NEA.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2006
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company